Clinical utility of periodic reinterpretation of CNVs of uncertain significance: an 8-year retrospective study
Abstract Background Array-CGH is the first-tier genetic test both in pre- and postnatal developmental disorders worldwide. Variants of uncertain significance (VUS) represent around 10~15% of reported copy number variants (CNVs). Even though VUS reanalysis has become usual in practice, no long-term s...
Main Authors: | Jean-Marie Ravel, Mathilde Renaud, Jean Muller, Aurélie Becker, Émeline Renard, Thomas Remen, Geneviève Lefort, Mylène Dexheimer, Philippe Jonveaux, Bruno Leheup, Céline Bonnet, Laëtitia Lambert |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Genome Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13073-023-01191-6 |
Similar Items
-
MAGI-ACMG: Algorithm for the Classification of Variants According to ACMG and ACGS Recommendations
by: Francesca Cristofoli, et al.
Published: (2023-08-01) -
A new direction for prenatal chromosome microarray testing: software-targeting for detection of clinically significant chromosome imbalance without equivocal findings
by: Joo Wook Ahn, et al.
Published: (2014-04-01) -
Reinterpretation of Ethic Value in Minangkabau’s Superstition
by: Ridha Hasnul Ulya
Published: (2018-09-01) -
Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight BRCA1 variants of uncertain significance by integrating available functional data with protein interaction assays
by: Laura Caleca, et al.
Published: (2023-04-01) -
AutoCNV: a semiautomatic CNV interpretation system based on the 2019 ACMG/ClinGen Technical Standards for CNVs
by: Chunna Fan, et al.
Published: (2021-10-01)